fda banned tirzepatide Ban on Compounded GLP-1 Drugs: What to Know Eli Lilly's tirzepatide is off

In clinical studies, Wegovy users experienced a significant weight reduction, losing 14.9% to 17.4% of their initial body weight over 68 weeks, greatly surpassing results typically seen with just diet and exercise

While individual results vary, GLP-1 medications have been studied for their ability to: Help regulate blood sugar levels Influence appetite regulation Support sustained lifestyle changes For instance, a 68-week clinical trial found that participants taking semaglutide along with lifestyle intervention had significantly greater improvements compared to placebo

Compared with previous AOMs, novel agents, such as semaglutide and tirzepatide, promote more weight loss

That is a pretty impressive response that you wont get from taking a GLP-1 injectable

Ibrahim et al., 2008)